Bone Metastasis From Solid Tumors Clinical Trial
Official title:
A Randomized, Double-blinded and Parallel Study to Assess the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults
A randomized, double-blind and parallel group study to compare the pharmacokinetic, pharmacodynamic, safety and immunogenicity of HS-20090 120mg（1.7ml）and Xgeva® in healthy adults.
This is a phase I, single center, randomized, double-blind and parallel group clinical trial
.
The primary objective is to assess the pharmacokinetic similarity of single subcutaneously
injection of HS-20090 or Xgeva® in healthy volunteers.
The secondary objectives are to assess the Clinical safety and immunogenicity similarity of
single subcutaneously injection of HS-20090 or Xgeva® in healthy volunteers.
Meanwhile，observing the pharmacodynamic similarity of HS-20090 to Xgeva® preliminarily.
;